Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Gets California OK for Clinical Lab

NEW YORK (GenomeWeb News) – California health officials have cleared Transgenomic to offer its molecular lab services in the state by certifying its lab, the company said today.

The company said it expects to start marketing a number of its services to California doctors right away, including tests for mitochondrial disorders, oncology, hematology, molecular pathology, and inherited diseases.

The company said its lab is CLIA certified, is compliant with Good Laboratory Practices, and is accredited by the College of American Pathologists.

Company CEO Craig Tuttle said in a statement that Transgenomic underwent a "rigorous certification process" to obtain the state license. "The state of California represents the largest market opportunity in the United States" for the company's molecular lab testing services, he added.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.